Pfizer and Moderna promised a quick delivery of the vaccine. Officials at the two drug companies say they are supplying the Covid 19 vaccine to the United States
Trying to accelerate the work further. They started more vaccine plants
Enough to bring the entire population of the United States under vaccination
The vaccine will be rolled out by the end of July. However, low income
Countries are still lagging behind in this vaccination line. According to a VOA correspondent, Steve Baragona, in a report,
Many people are annoyed enough to wait too long for vaccines and that is why
There is a need to expedite the delivery of the Covid 19 vaccine to the market
Available. But pharmaceutical company officials told Congress in the United States on Tuesday
He said that they are providing vaccines in a big way.
“We recognize the need to vaccinate more people faster and work hard to increase productivity,” said John Young, Pfizer’s chief business officer. The company has expanded production and added a production line. “As a result of these improvements, we will be able to produce approximately 13 million doses per week, starting at about 4 million to 5 million doses per week in early February and approximately 13 million by mid-March.” I look forward to it. ”
Modern President Stephen Hogg told Congress that production at his company has also increased significantly.
By the end of July, the two companies are expected to deliver a combined 600 million doses, enough to vaccinate 300 million people in two doses.
A third vaccine is coming to market soon. Johnson and Johnson need only one dose of this vaccine. Unlike Pfizer and modern vaccines, it does not need to be kept in extremely cold temperatures. It will be 75 percent effective against serious diseases – a little less effective than the other two, but it will work very well, says William Moss, a vaccine specialist at Johns Hopkins University. “If a single dose of this vaccine works, and can only be stored at refrigerator temperature, it will be very convenient for many countries,” said Mr William Moss.
Johnson and Johnson’s vaccine hearing will be held on Friday, February 26, before approval, but it is a very important step. Although many countries have to wait for these vaccines. Mesfin Tesema, head of the International Rescue Committee’s health unit, said companies could increase production, but added that “while this announcement is welcome news, adequate production in low-income countries could be available by the end of 2021 or 2022.”
Pfizer has sold 40 million doses to low-income countries this year under the World Health Organization-backed Kovacs program. Johnson and Johnson have sold 10 crores. More vaccines are coming from AstraZeneca. But experts say more vaccine factories around the world will be needed for the vaccine to reach 6,700 billion people worldwide.
